Literature DB >> 5467580

The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.

K A Woeber, R J Sobel, S H Ingbar, K Sterling.   

Abstract

In order to assess the contribution of 3.3',5-triiodo-L-thyronine (T(3)) to overall thyroid hormone economy, conjoint measurements of the kinetics of peripheral T(3) metabolism and the total concentration of T(3) in serum were made in a group of normal subjects and in a group of patients with hyperthyroid Graves' disease. As judged from the disappearance of trichloroacetic acid-precipitable (131)I from serum after a single intravenous dose of labeled T(3), the following mean values were obtained in the normal subjects: volume of distribution, 43 liters or 0.62 liter/kg; fractional turnover rate. 52% per 24 hr: clearance rate, 22.3 liters/24 hr: and absolute disposal rate, 60 mug/24 hr. In the patients with untreated hyperthyroidism, values for all these functions were greatly increased. After treatment, the volume of T(3) distribution returned to normal but the fractional turnover rate remained abnormally rapid.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5467580      PMCID: PMC322518          DOI: 10.1172/JCI106275

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Disappearance of I-131-triiodo-thyronine from the plasma in the presence of fever.

Authors:  J G WISWELL; V CORONHO
Journal:  J Clin Endocrinol Metab       Date:  1962-06       Impact factor: 5.958

2.  Studies of thyroid function and the peripheral metabolism of I 131-labeled thyroxine in patients with treated Graves disease.

Authors:  S H INGBAR; N FREINKEL
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

3.  The metabolism of triiodothyronine in Graves' disease.

Authors:  I B HALES; B M DOBYNS
Journal:  J Clin Endocrinol Metab       Date:  1960-01       Impact factor: 5.958

4.  Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects.

Authors:  K STERLING; J C LASHOF; E B MAN
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

5.  Estimation of thyroxine distribution in man.

Authors:  J T Nicoloff; J T Dowling
Journal:  J Clin Invest       Date:  1968-01       Impact factor: 14.808

6.  Formation of iodoprotein during the peripheral metabolism of 3,5,3'-triiodo-L-thyronine-125I in the euthyroid man and rat.

Authors:  M I Surks; J H Oppenheimer
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

7.  A simplified method for butanol-extractable iodine and butanol-insoluble iodine.

Authors:  J Benotti; S Pino
Journal:  Clin Chem       Date:  1966-08       Impact factor: 8.327

8.  Total and free triiodothyronine in human serum.

Authors:  J A Nauman; A Nauman; S C Werner
Journal:  J Clin Invest       Date:  1967-08       Impact factor: 14.808

9.  Thyroid hormone transport in the serum of patients with thyrotoxic Graves' disease before and after treatment.

Authors:  L E Braverman; A E Foster; S H Ingbar
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

10.  Thyroxine transport in thyrotoxicosis and hypothyroidism.

Authors:  M Inada; K Sterling
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

View more
  15 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Authors:  Benjamin Van Tassell; George F Wohlford; Joyce D Linderman; Sheila Smith; Sahzene Yavuz; Frank Pucino; Francesco S Celi
Journal:  Thyroid       Date:  2019-09-12       Impact factor: 6.568

Review 4.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

5.  The extrathyroidal conversion rate of thyroxine to triiodothyronine in normal man.

Authors:  C S Pittman; J B Chambers; V H Read
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

6.  Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects.

Authors:  L E Braverman; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

7.  Triiodothyronine radioimmunoassay.

Authors:  J Lieblich; R D Utiger
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

8.  Serum triiodothyronine: measurements in human serum by radioimmunoassay with corroboration by gas-liquid chromatography.

Authors:  T Mitsuma; N Nihei; M C Gershengorn; C S Hollander
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

9.  A new radioimmunoassay for plasma L-triiodothyronine: measurements in thyroid disease and in patients maintained on hormonal replacement.

Authors:  M I Surks; A R Schadlow; J H Oppenheimer
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

10.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.